ArticlePloS one2024

Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis.

Matthew D Gregory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.